Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Precision Therapeutics Inc (AIPT)

Precision Therapeutics Inc (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,635
  • Shares Outstanding, K 30,680
  • Annual Sales, $ 1,410 K
  • Annual Income, $ -10,090 K
  • 60-Month Beta 2.12
  • Price/Sales 13.04
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.84
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.40 +59.56%
on 05/22/19
0.66 -3.03%
on 05/14/19
-0.01 (-1.99%)
since 05/13/19
3-Month
0.40 +59.56%
on 05/22/19
0.96 -33.33%
on 03/21/19
-0.17 (-21.09%)
since 03/13/19
52-Week
0.40 +59.56%
on 05/22/19
1.58 -59.49%
on 07/13/18
-0.56 (-46.67%)
since 06/13/18

Most Recent Stories

More News
Precision Therapeutics' Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant

Precision Therapeutics Inc., (Nasdaq: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that its Helomics...

AIPT : 0.64 (+6.67%)
MRK : 84.94 (-2.05%)
BLFS : 19.31 (-6.89%)
CELGZ : 0.55 (+1.97%)
Precision Therapeutics Gains Extension for Nasdaq Compliance

Precision Therapeutics Inc. (Nasdaq: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that Nasdaq...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Precision Therapeutics Inc. (Nasdaq: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, today announced financial results...

AIPT : 0.64 (+6.67%)
Precision Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 15, 2019 / Precision Therapeutics, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 15, 2019 at 4:30 PM Eastern...

AIPT : 0.64 (+6.67%)
Precision Therapeutics to Report First Quarter 2019 Financial Results and Provide Company Update on Wednesday, May 15, 2019

Conference Call to be held May 15, 2019, at 4:30pm Eastern Time

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced a services agreement between its wholly owned subsidiary, Helomics and the National Alopecia Areata Foundation...

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Receive Alberta Innovates Product Demonstration Program Grant to Support Development of Novel Cancer Treatments

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced that its wholly owned subsidiary, TumorGenesis, is participating with 48Hour Discovery (48HD), a Canadian partner,...

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Subsidiary, Helomics(R) Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced that its wholly-owned subsidiary, Helomics(R) Corporation (Helomics), which provides personalized medicine solutions...

AIPT : 0.64 (+6.67%)
Uptick Newswire Hosts Precision Therapeutics Inc. on The Stock Day Podcast to Discuss Massive Revenue Increases

PHOENIX, AZ / ACCESSWIRE / April 11, 2019 / Uptick Newswire Stock Day Podcast welcomed Precision Therapeutics Inc. (NASDAQ: ) ("the Company"), a company with business lines that include applying artificial...

AIPT : 0.64 (+6.67%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics' Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced a collaboration between its wholly owned subsidiary, Helomics, and Viome, a new kind of healthcare company transforming...

AIPT : 0.64 (+6.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade AIPT with:

Business Summary

Precision Therapeutics Inc. operating business areas includes development of a healthcare CRO which provides personalized medicine solutions for clients in the pharmaceutical, diagnostic and biotech industries as well as production of the FDA-approved STREAMWAY(R) System for automated, direct-to-drain...

See More

Key Turning Points

2nd Resistance Point 0.68
1st Resistance Point 0.66
Last Price 0.64
1st Support Level 0.61
2nd Support Level 0.59

See More

52-Week High 1.58
Fibonacci 61.8% 1.13
Fibonacci 50% 0.99
Fibonacci 38.2% 0.85
Last Price 0.64
52-Week Low 0.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar